期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
PLX8394,a RAF inhibitor,inhibits enterovirus 71 replication by blocking RAF/MEK/ERK signaling
1
作者 Chengyuan Wu Guangyan Zhu +5 位作者 Fang Qiu Fuli Ren Binbin Lin Dingyu Zhang Qingyu Yang Chaolin Huang 《Virologica Sinica》 SCIE CAS CSCD 2023年第2期276-284,共9页
Enterovirus 71(EV71)poses a serious threat to human health,with scattered outbreaks worldwide.There are several vaccines against a few EV71 strains but no efficient drug for the treatment of EV71 infection.Therefore,i... Enterovirus 71(EV71)poses a serious threat to human health,with scattered outbreaks worldwide.There are several vaccines against a few EV71 strains but no efficient drug for the treatment of EV71 infection.Therefore,it is urgent and of significance to develop anti-EV71 drugs.Here,we found that PLX8394,a RAF inhibitor,possesses high antiviral activity against EV71 in vitro,being superior to the traditional clinical drug ribavirin.Moreover,PLX8394 exhibits broad-spectrum antiviral activity against enteroviruses.Notably,in a suckling mouse model,PLX8394 provided a 70%protection rate for EV71-infected mice,reduced the viral load in liver and heart tissues,and relieved the inflammatory response.A mechanistic study showed that PLX8394 inhibited EV71 by suppressing the RAF/MEK/ERK signaling pathway.Thus,PLX8394 lays a foundation for the development of new drugs against EV71. 展开更多
关键词 Enterovirus 71(EV71) raf inhibitor Hand foot and mouth disease(HFMD) raf/mek/erk signaling pathway Antiviral agents
原文传递
Apoptosis in glioma-bearing rats after neural stem cell transplantation 被引量:5
2
作者 Hua Li Zhenjun Chen Shaopeng Zhou 《Neural Regeneration Research》 SCIE CAS CSCD 2013年第19期1793-1802,共10页
Abnormal activation of the Ras/Raf/Mek/Erk signaling cascade plays an important role in glioma. Inhibition of this aberrant activity could effectively hinder glioma cell proliferation and promote cell apoptosis. To in... Abnormal activation of the Ras/Raf/Mek/Erk signaling cascade plays an important role in glioma. Inhibition of this aberrant activity could effectively hinder glioma cell proliferation and promote cell apoptosis. To investigate the mechanism of gJioblastoma treatment by neural stem ceiJ trans- plantation with respect to the Ras/Raf/Mek/Erk pathway, C6 glioma cells were prepared in sus- pension and then infused into the rat brain to establish a glioblastoma model. Neural stem cells isolated from fetal rats were then injected into the brain of this glioblastoma model. Results showed that Raf-1, Erk and Bcl-2 protein expression significantly increased, while Caspase-3 protein expression decreased. After transplantation of neural stem cells, Raf-1, Erk and Bcl-2 protein expression significantly decreased, while Caspase-3 protein expression significantly in-creased. Our findings indicate that transplantation of neural stem cells may promote apoptosis of glioma cells by inhibiting Ras/Raf/Mek/Erk signaling, and thus may represent a novel treatment approach for glioblastoma. 展开更多
关键词 neural regeneration stem cells Ras/raf/mek/erk signaling pathway neural stem cells glioblas-toma C6 glioma cells Caspase-3 Bcl-2 APOPTOSIS brain tumor NEUROREGENERATION
下载PDF
lncRNA ARHGAP5-AS1靶向调控miR-155-5p抑制肾癌细胞增殖和侵袭
3
作者 沈旭 李庆伟 +1 位作者 王刚 肖彬 《国际外科学杂志》 2024年第10期677-681,I0004,I0005,共7页
目的探讨lncRNA ARHGAP5-AS1在肾癌组织和细胞株中的表达及其对肾癌细胞株增殖和侵袭的影响及其分子机制。方法采用GEPIA数据库分析肾癌组织中ARHGAP5-AS1的表达,并分析其与肾癌患者临床分期、总生存期和无病生存期的关系。采用实时荧... 目的探讨lncRNA ARHGAP5-AS1在肾癌组织和细胞株中的表达及其对肾癌细胞株增殖和侵袭的影响及其分子机制。方法采用GEPIA数据库分析肾癌组织中ARHGAP5-AS1的表达,并分析其与肾癌患者临床分期、总生存期和无病生存期的关系。采用实时荧光定量聚合酶链反应(RT-qPCR)法检测肾癌细胞(786-O、Caki-1、OS-RC-2、ACHN、A-498)中ARHGAP5-AS1的表达水平。向肾癌OS-RC-2细胞中转染pcDNA3.1-ARHGAP5-AS1质粒或pcDNA3.1质粒,记为ARHGAP5-AS1组和对照组。采用集落形成实验和Transwell实验检测OS-RC-2细胞增殖和侵袭能力的改变。采用双荧光素酶报告基因实验验证ARHGAP5-AS1和miR-155-5p的靶向关系。采用Starbase v3.0在线数据库分析ARHGAP5-AS1和miR-155-5p在肾癌组织中表达的相关性。采用RT-qPCR法检测miR-155-5p表达水平的变化。Western blotting法检测Raf/MEK/ERK分子通路蛋白p-Raf、p-MEK、p-ERK、p-FBW7、c-MYC的表达变化。计量资料以均数±标准差(±s)表示,两组间比较采用独立样本t检验,多组间比较采用单因素方差分析。结果ARHGAP5-AS1在肾癌组织中呈低表达(P<0.01),其表达水平与肾癌患者临床分期、总生存期和无病生存期均有关(P<0.01)。ARHGAP5-AS1在肾癌细胞株(786-O、Caki-1、OS-RC-2、ACHN、A-498)中均呈低表达(P<0.01)。与对照组相比,ARHGAP5-AS1组OS-RC-2细胞的增殖能力和侵袭能力均显著降低(P<0.01)。双荧光素酶报告基因实验证实ARHGAP5-AS1靶向结合miR-155-5p(P<0.01)。ARHGAP5-AS1与miR-155-5p在肾癌组织中的表达呈负相关(P<0.01)。与对照组相比,ARHGAP5-AS1组OS-RC-2细胞中miR-155-5p表达显著降低(P<0.01)。与对照组相比,ARHGAP5-AS1组OS-RC-2细胞中Raf/MEK/ERK分子通路蛋白p-Raf、p-MEK、p-ERK、p-FBW7、c-MYC表达水平降低。结论lncRNA ARHGAP5-AS1在肾癌组织中低表达并与肾癌患者临床分期和生存期相关,ARHGAP5-AS1靶向调控miR-155-5p表达抑制肾癌细胞的增殖和侵袭。 展开更多
关键词 肾肿瘤 微RNAs 细胞增殖 ARHGAP5-AS1 MiR-155-5p raf/mek/erk分子通路 侵袭
原文传递
整合药理学方法的心可舒片干预动脉粥样硬化作用网络机制探讨 被引量:9
4
作者 李晓宇 徐男 +5 位作者 黄娜娜 吴成胜 刘闰平 郭文鹤 李晓骄阳 孙蓉 《中草药》 CAS CSCD 北大核心 2018年第15期3463-3470,共8页
目的探究心可舒片干预动脉粥样硬化(AS)作用的分子机制,对于心可舒片二次开发和临床应用提供参考。方法用整合药理学平台对心可舒片干预AS的关键靶点和通路进行预测,探究其干预AS的分子机制。结果通过建立心可舒片"中药-成分-靶点... 目的探究心可舒片干预动脉粥样硬化(AS)作用的分子机制,对于心可舒片二次开发和临床应用提供参考。方法用整合药理学平台对心可舒片干预AS的关键靶点和通路进行预测,探究其干预AS的分子机制。结果通过建立心可舒片"中药-成分-靶点-通路"网络进行预测和分析,得到相关有效成分80个,确定了B4GALT4、B4GALT2、PRKCD、GCK、GNB1等关键靶点,明确了内分泌系统、甲状腺激素、神经系统、雌性激素和趋化因子等富集通路与其抗AS作用相关。结论心可舒片通过对PI3K/Akt/eNOS和Raf/MEK/ERK途径的共同调节,保护血管内皮细胞,从而达到干预AS的效果。 展开更多
关键词 心可舒片 动脉粥样硬化 整合药理学平台 分子机制 PI3K/Akt/eNOS通路 raf/mek/erk通路
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部